James has over 25 years of life sciences leadership experience in various business, corporate, and strategic alliance capacities. He has held positions of increasing responsibility from Abbott Laboratories during the 1990’s to Sun Pharmaceutical Industries through 2014, having recently accepted to serve in a global role at Adherium. James has successfully completed numerous revenue-generating transactions with SMID and large cap multi-national pharmaceutical firms in North America, Europe, and the Asia-Pacific region. Academic background includes receipt of graduate and undergraduate degrees in biochemistry and neurobiology, respectively, from University of California. In addition, James completed post-graduate studies in financial analytics at University of Chicago GSB. Jim serves on the Board of Directors of Temple Therapeutics BV.